Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
NASDAQ:ITRM
Price:
1.61 USD
0.63%
Market Closed
Updated:
May 10, 2024
Balance Sheet
Balance Sheet Decomposition
Iterum Therapeutics PLC
Iterum Therapeutics PLC
| Current Assets | 25.6m |
| Cash & Short-Term Investments | 23.9m |
| Receivables | 38k |
| Other Current Assets | 1.6m |
| Non-Current Assets | 663k |
| PP&E | 600k |
| Other Non-Current Assets | 63k |
| Current Liabilities | 13.5m |
| Accounts Payable | 5m |
| Accrued Liabilities | 8.1m |
| Other Current Liabilities | 396k |
| Non-Current Liabilities | 19.1m |
| Long-Term Debt | 19m |
| Other Non-Current Liabilities | 188k |
Balance Sheet
Iterum Therapeutics PLC
Iterum Therapeutics PLC
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
25
|
8
|
45
|
5
|
15
|
27
|
21
|
6
|
|
| Cash Equivalents |
25
|
8
|
45
|
5
|
15
|
27
|
21
|
6
|
|
| Short-Term Investments |
0
|
32
|
41
|
1
|
2
|
54
|
40
|
18
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
3
|
7
|
6
|
5
|
2
|
1
|
2
|
|
| Total Current Assets |
26
|
44
|
93
|
12
|
21
|
83
|
62
|
26
|
|
| PP&E Net |
0
|
1
|
1
|
8
|
6
|
4
|
2
|
1
|
|
| PP&E Gross |
0
|
1
|
1
|
8
|
6
|
4
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
0
|
|
| Other Long-Term Assets |
1
|
2
|
4
|
6
|
6
|
1
|
1
|
0
|
|
| Total Assets |
27
N/A
|
47
+74%
|
98
+109%
|
26
-74%
|
33
+27%
|
92
+179%
|
67
-27%
|
26
-61%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
3
|
4
|
15
|
1
|
1
|
3
|
5
|
|
| Accrued Liabilities |
3
|
4
|
7
|
13
|
2
|
2
|
5
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
6
|
6
|
2
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
3
|
32
|
9
|
2
|
0
|
|
| Total Current Liabilities |
4
|
7
|
12
|
37
|
42
|
13
|
9
|
14
|
|
| Long-Term Debt |
0
|
0
|
13
|
8
|
36
|
25
|
28
|
19
|
|
| Other Liabilities |
0
|
0
|
1
|
7
|
6
|
3
|
1
|
0
|
|
| Total Liabilities |
4
N/A
|
7
+71%
|
26
+264%
|
52
+98%
|
83
+60%
|
41
-50%
|
39
-6%
|
33
-16%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Retained Earnings |
25
|
55
|
132
|
235
|
287
|
378
|
423
|
461
|
|
| Additional Paid In Capital |
48
|
94
|
203
|
209
|
236
|
427
|
451
|
455
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
23
N/A
|
40
+74%
|
72
+81%
|
26
N/A
|
51
-93%
|
50
N/A
|
28
-44%
|
6
N/A
|
|
| Total Liabilities & Equity |
27
N/A
|
47
+74%
|
98
+109%
|
26
-74%
|
33
+27%
|
92
+179%
|
67
-27%
|
26
-61%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
3
|
12
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
